A Study to Evaluate the Efficacy of Bevacizumab in Combination With Tarceva for Advanced Non-Small Cell Lung Cancer
Clinical trial NCT00130728 · COMPLETED
Trial details
- NCT number
- NCT00130728
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-08
- Primary completion
- 2008-07-15
- Enrollment
- 636
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.